The short version
10 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Bisoprolol fumarate
Bisoprolol fumarate · BISOPROLOL FUMARATE 10 mg/1 · Tablet · Oral · Natco Pharma USA LLC
NDC 69339-0237-03 · 30 TABLET in 1 BOTTLE, PLASTIC · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 29300-0127-01) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$0.3969per unit
middle half $0.3208–$0.4912 · 5,494 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.3969
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 2 · prior auth 0% · step therapy 0% · qty limit 0%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 2 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for bisoprolol fumarate (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Natco Pharma LimitedIndiamanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA075831
- TE code
- —
- Approval date
- Dec 14, 2005
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Bisoprolol fumarate (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bryant Ranch Prepack | BISOPROLOL FUMARATE 5 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| American Health Packaging | BISOPROLOL FUMARATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bryant Ranch Prepack | BISOPROLOL FUMARATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | BISOPROLOL FUMARATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | BISOPROLOL FUMARATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Harman Finochem Limited | BISOPROLOL FUMARATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Harman Finochem Limited | BISOPROLOL FUMARATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Natco Pharma USA LLC | BISOPROLOL FUMARATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Natco Pharma USA LLC | BISOPROLOL FUMARATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Novitium Pharma LLC | BISOPROLOL FUMARATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Novitium Pharma LLC | BISOPROLOL FUMARATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals Inc. | BISOPROLOL FUMARATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | BISOPROLOL FUMARATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Solco Healthcare US, LLC | BISOPROLOL FUMARATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Solco Healthcare US, LLC | BISOPROLOL FUMARATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Unichem Pharmaceuticals (USA), Inc. | BISOPROLOL FUMARATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Unichem Pharmaceuticals (USA), Inc. | BISOPROLOL FUMARATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Bisoprolol fumarate — NDC 69339-0237-03," retrieved September 3, 2026, https://drugdashboards.com/drug/69339023703.
Free to cite with attribution — see how the data is put together.